Abstract:Background Non-coding RNAs (ncRNAs), including small nucleolar RNAs (snoRNAs), are widely involved in the physiological and pathological processes of human beings. While up to date, although considerable progress has been achieved in ncRNA-related pathogenesis of non-small cell lung cancer (NSCLC), the underlying mechanisms and biological significance of snoRNAs in NSCLC still need to be further clarified. Methods Quantitative real-time polymerase chain reaction or RNAscope was performed to verify the expression of Small Nucleolar RNA, H/ACA Box 38B (SNORA38B) in NSCLC cell lines or clinical samples. BALB/c nude mice xenograft model or C57BL/6J mice syngeneic tumor model were estimated to detect the effects of SNORA38B in tumor growth or tumor immune microenvironment in vivo. Cytometry by time of flight, enzyme-linked immunosorbent assay and flow cytometry assay were conducted to clarify the effects and mechanisms of SNORA38B-mediated tumor immunosuppressive microenvironment. The binding activity between SNORA38B and E2F transcription factor 1(E2F1) was detected by RNA immunoprecipitation and RNA pull-down assays. Then, bioinformatics analysis and chromatin immunoprecipitation were utilized to demonstrate the regulation of GRB2-associated-binding protein 2 (GAB2) by E2F1. Moreover, the combinatorial treatment of SNORA38B locked nucleic acid (LNA) and immune checkpoint blockade (ICB) was used to treat murine Lewis lung carcinoma-derived tumor burden C57BL/6J mice to clarify the effectiveness of targeting SNORA38B in NSCLC immunotherapy. Results SNORA38B was found highly expressed in NSCLC tissues and cell lines, and associated with worse prognosis. Further results showed that SNORA38B functioned as an oncogene via facilitating cell proliferation, migration, invasion, and inhibiting cell apoptosis in vitro and promoting tumorigenesis of NSCLC cells in vivo. SNORA38B could also recruit the CD4 + FOXP3 + regulatory T cells by triggering tumor cells to secrete interleukin 10, which in turn reduced the infiltration of CD3 + CD8 + T cells in NSCLC tumor microenvironment (TME), favoring tumor progression and poorer immune efficacy. Mechanistically, SNORA38B mainly distributed in the nucleus, and promoted NSCLC progression by regulating GAB2 transcription to activate protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway through directly binding with E2F1. Moreover, we found that SNORA38B LNAs were able to ameliorate CD3 + CD8 + T cell infiltration in TME, which sensitized NSCLC to the treatment of ICB. Conclusions In conclusion, our data demonstrated that SNORA38B functioned as an oncogene in NSCLC both in vitro and in vivo at least in part by regulating the GAB2/AKT/mTOR pathway via directly binding to E2F1. SNORA38B could also sensitize NSCLC to immunotherapy, which may be a critical therapeutic target for NSCLC.

Overexpression of TSPAN8 Promotes Tumor Cell Viability and Proliferation in Nonsmall Cell Lung Cancer.

HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFβ1 in non-small cell lung cancer

Expression of Long Non-Coding RNA SFTA1P and Its Function in Non-Small Cell Lung Cancer

SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway

TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling

The role of ATP8A1 in non-small cell lung cancer

Clinical Significance and Biological Roles of SPAG9 Overexpression in Non-Small Cell Lung Cancer

Actin‐like Protein 8 Promotes Cell Proliferation, Colony‐formation, Proangiogenesis, Migration and Invasion in Lung Adenocarcinoma Cells

Gene amplification-driven lncRNA SNHG6 promotes tumorigenesis via epigenetically suppressing p27 expression and regulating cell cycle in non–small cell lung cancer

Lentivirus-Mediated Knockdown of Tsp50 Suppresses the Growth of Non-Small Cell Lung Cancer Cells Via G0/G1 Phase Arrest

The USP21/YY1/SNHG16 Axis Contributes to Tumor Proliferation, Migration, and Invasion of Non-Small-cell Lung Cancer

TMSB4X: A novel prognostic marker for non-small cell lung cancer

TSPAN8 Serves As a Prognostic Marker Involving Akt/MAPK Pathway in Nasopharyngeal Carcinoma.

Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway

The Overexpression of 14‐3‐3ζ and Hsp27 Promotes Non–small Cell Lung Cancer Progression

Tspan8 is Highly Expressed in Clear Cell Renal Cell Carcinoma and Indicates Poor Prognosis.

Molecular Regulation and Oncogenic Functions of TSPAN8

Overexpression of NOP58 Facilitates Proliferation, Migration, Invasion, and Stemness of Non-small Cell Lung Cancer by Stabilizing hsa_circ_0001550

Prognostic implication of ITGB8 and its relationship with immune response

SLC12A8 promotes the migration and invasion of non-small cell lung cancer (NSCLC) cells

Increased Expression of TAP is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer